论文部分内容阅读
急性髓系白血病(AML)是造血系统的恶性克隆性疾病,20世纪70年代初开始应用DA方案治疗AML,使AML的疗效得到明显的提高。国内应用HA(高三尖杉酯碱联合阿糖胞苷)获得了与DA方案相似的疗效。40年来,DA方案仍然是国际上
Acute myeloid leukemia (AML) is a malignant clonal disease of the hematopoietic system. The application of DA regimen to AML in the early 1970s has greatly improved the efficacy of AML. The domestic application of HA (homoharringtonine combined with cytarabine) obtained similar efficacy with the DA regimen. For 40 years, the DA program is still international